Zymeworks

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zymeworks and other ETFs, options, and stocks.

About ZYME

Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Its product includes Zanidatamab, which is a novel bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2).

CEO

Kenneth Harry Galbraith

CEOKenneth Harry Galbraith

Employees

277

Employees277

Headquarters

Middletown, Delaware

HeadquartersMiddletown, Delaware

Founded

2003

Founded2003

Employees

277

Employees277

ZYME Key Statistics

Market cap

980.61M

Market cap980.61M

Price-Earnings ratio

-9.38

Price-Earnings ratio-9.38

Dividend yield

—

Dividend yield—

Average volume

623.80K

Average volume623.80K

High today

$14.15

High today$14.15

Low today

$12.89

Low today$12.89

Open price

$13.32

Open price$13.32

Volume

1.55M

Volume1.55M

52 Week high

$17.70

52 Week high$17.70

52 Week low

$7.97

52 Week low$7.97

ZYME News

TipRanks 6d

Zymeworks upgraded to Overweight from Neutral at JPMorgan

JPMorgan upgraded Zymeworks (ZYME) to Overweight from Neutral with an $18 price target Pick the best stocks and maximize your portfolio: Discover top-rated sto...

Analyst ratings

75%

of 8 ratings

Buy

75%

Hold

25%

Sell